Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DQ7I6M
|
|||
| Drug Name |
ARCT-810
|
|||
| Drug Type |
mRNA therapy
|
|||
| Indication | Ornithine transcarbamylase deficiency [ICD-11: 5C50.AY] | Phase 2 | [1] | |
| Company |
Arcturus Therapeutics
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Ornithine transcarbamylase (OTC) | Target Info | . | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Arcturus Therapeutics | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.